United States Leads the Global Diabetes Drugs Market The United States remains the largest diabetes drugs market globally due to high disease prevalence, advanced healthcare infrastructure, and strong adoption of innovative therapies
The first GLP-1 receptor agonist was approved for diabetes treatment in 2005
to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes mellitus with known heart disease
And with conditions such as hypothyroidism or Hashimoto's, it never seems to go down, no matter how much you exercise or changes you make in your eating habits
Tell your healthcare provider if you are taking medicines to treat diabetes including an insulin or sulfonylurea which could increase your risk of low blood sugar
Acute kidney injury can occur in cases of severe dehydration from persistent vomiting or diarrhea